tofacitinib modified-release (MR) formulation
Sponsors
Pfizer
Conditions
Healthy
Phase 1
A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers
CompletedNCT01731327
Start: 2012-11-30End: 2012-12-31Updated: 2012-12-24
A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers
CompletedNCT02084875
Start: 2014-04-11End: 2014-05-25Updated: 2018-11-30